Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Nurse Charged with Distributing Fake Ozempic to Patients - Featured image
GLP-1 Medications

Nurse Charged with Distributing Fake Ozempic to Patients

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 15, 2026·2 min read

On this page

  • Details of the Counterfeit Ozempic Case
  • Ozempic Demand and Shortages
  • Risks of Rapid Weight Loss with GLP-1 Drugs
  • Court Proceedings

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A nurse faces federal charges for providing counterfeit Ozempic injections to patients. The fake drugs lacked semaglutide, the active ingredient for type 2 diabetes treatment. Rising demand for weight loss has fueled shortages and illegal alternatives.

Share

On this page

  • Details of the Counterfeit Ozempic Case
  • Ozempic Demand and Shortages
  • Risks of Rapid Weight Loss with GLP-1 Drugs
  • Court Proceedings

A registered nurse has been charged in federal court for allegedly distributing counterfeit Ozempic to patients.

Details of the Counterfeit Ozempic Case

Sharon Charitine Sackman, 52, from Chicago, was arrested for providing three people with injections falsely labeled as Ozempic in 2023. Prosecutors allege the drugs were not manufactured by the official producer and contained no semaglutide, the key ingredient for treating type 2 diabetes.

Sackman, now residing in Playa del Carmen, Mexico, is not licensed to prescribe, dispense, or sell the medication. The counterfeit products posed serious health risks to patients expecting legitimate treatment.

Ozempic Demand and Shortages

Though not officially approved for weight loss, Ozempic has surged in popularity for slimming. This off-label use has caused widespread shortages and increased illegal alternatives outside approved channels.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Federal officials state Sackman exploited this demand by supplying misbranded drugs.

Court Proceedings

  • Charged with one count of distributing misbranded drugs and three counts of dispensing counterfeit drugs.
  • Entered a not guilty plea in Chicago federal court.
  • Each count carries up to one year in prison if convicted.
  • Next hearing scheduled for February 3 before Judge Laura K. McNally.

The U.S. Attorney's Office notes these are allegations; Sackman is presumed innocent until proven guilty.

Risks of Rapid Weight Loss with GLP-1 Drugs

Beyond counterfeits, rapid weight loss from GLP-1 medications like Ozempic raises concerns. Aesthetic specialist Roy Cowley warns of gaunt appearances.

"Really, anyone you see who's had very rapid weight loss, generally it's down to these Ozempic-type fat-loss jabs. It's the gaunt appearance - sunken cheeks, hollow eyes, sagging skin and more prominent wrinkles. Skin doesn't always bounce back, especially when weight drops quickly."

Fast weight loss from any method can cause these effects, emphasizing the need for evidence-based approaches.

Source Information

Originally published by Mirror.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less
Medical Insights

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

New data presented at ENDO 2026 reveals a paradox: patients on GLP-1 medications like Ozempic and Wegovy reduced their physical activity despite losing weight.

8 min read
Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging
Medical Research

Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging

A new clinical trial suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may help slow biological processes associated with aging in adults with HIV.

8 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
Health & Wellness

Yes, GLP-1s Make You Thinner. But Do They Make You Freer?

While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.

8 min read

More in GLP-1 Medications

Ozempic Reshaping Beauty Standards Toward Thinness
GLP-1 Medications

Ozempic Reshaping Beauty Standards Toward Thinness

Ozempic, originally for diabetes, has sparked a cultural shift toward extreme thinness as the new beauty ideal. This rapid reversal from body positivity creates intense social pressures and physical risks like muscle loss. Understand the implications for body image and long-term health.

2 min read
Heather Gay: Sticking with GLP-1s After 25-lb Loss
GLP-1 Medications

Heather Gay: Sticking with GLP-1s After 25-lb Loss

Heather Gay, star of Real Housewives of Salt Lake City, shares her commitment to GLP-1 medications like Ozempic after shedding 25 pounds. She prioritizes how she feels over scale numbers, pairing the drug with Atkins for protein-rich nutrition. Now in her 50s, she feels healthier and more body-confident than ever.

3 min read
Matt Cooper Defends Ozempic Users: Early Adopter Story
GLP-1 Medications

Matt Cooper Defends Ozempic Users: Early Adopter Story

Radio host Matt Cooper reveals his journey as an early Ozempic adopter for type 2 diabetes. He defends users struggling with weight, sharing how the GLP-1 drug curbs appetite and led to gallbladder removal. Learn from his candid experiences on semaglutide benefits and challenges.

2 min read
Share this article
  1. Home
  2. Blog
  3. Nurse Charged with Distributing Fake Ozempic to Patients
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community